0.3363
price up icon1.82%   0.006
after-market 시간 외 거래: .34 0.0037 +1.10%
loading
전일 마감가:
$0.3303
열려 있는:
$0.335
하루 거래량:
290.13K
Relative Volume:
0.24
시가총액:
$6.62M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-0.0358
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
-3.91%
1개월 성능:
-79.37%
6개월 성능:
-94.41%
1년 성능:
-98.70%
1일 변동 폭
Value
$0.3175
$0.3399
1주일 범위
Value
$0.3175
$0.4075
52주 변동 폭
Value
$0.25
$39.84

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
명칭
Cyclacel Pharmaceuticals Inc
Name
전화
908-517-7330
Name
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
CYCC's Discussions on Twitter

CYCC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CYCC
Cyclacel Pharmaceuticals Inc
0.3363 6.62M 74,000 -13.43M -10.54M -9.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-07-18 재개 Oppenheimer Outperform
2020-04-27 재개 ROTH Capital Buy
2018-09-07 개시 Ladenburg Thalmann Buy
2015-10-16 개시 H.C. Wainwright Buy
2010-02-04 개시 Roth Capital Buy
2009-10-28 개시 Merriman Buy
2008-08-12 개시 Piper Jaffray Buy
2008-03-12 재확인 Cantor Fitzgerald Buy
2008-03-12 재확인 Collins Stewart Buy
2008-03-12 재확인 Needham & Co Buy
2007-11-27 재확인 Cantor Fitzgerald Buy
2007-08-10 재확인 Cantor Fitzgerald Buy
2007-06-04 재확인 Needham & Co Buy
2007-04-23 개시 Lazard Capital Buy
2007-04-10 개시 Cantor Fitzgerald Buy
모두보기

Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스

pulisher
Jun 03, 2025

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Listing Rule - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Cyclacel Pharmaceuticals Declares Quarterly Cash Dividend - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Cyclacel Pharmaceuticals (CYCC) Regains Nasdaq Compliance | CYCC Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT | CYCC Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Cyclacel Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Cyclacel Dodges Delisting Risk: Stock Stabilizes Above $1, Secures Crucial Nasdaq Compliance - Stock Titan

Jun 03, 2025
pulisher
May 31, 2025

Comparing Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Biodexa Pharmaceuticals (NASDAQ:BDRX) - Defense World

May 31, 2025
pulisher
May 19, 2025

Cyclacel stock plunges to 52-week low of $1.95 amid market challenges - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

(CYCCP) Proactive Strategies - news.stocktradersdaily.com

May 19, 2025
pulisher
May 18, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World

May 18, 2025
pulisher
May 15, 2025

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Cyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib Development - Nasdaq

May 15, 2025
pulisher
May 12, 2025

Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail

May 12, 2025
pulisher
May 12, 2025

Fitters Clarifies Details Of Business Unit Disposal To Cyclacel - BusinessToday Malaysia

May 12, 2025
pulisher
May 11, 2025

Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Monday - Defense World

May 11, 2025
pulisher
May 10, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World

May 10, 2025
pulisher
May 08, 2025

Trend Tracker for (CYCCP) - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shares Scheduled to Reverse Split on Monday, May 12th - Defense World

May 08, 2025
pulisher
May 07, 2025

Cyclacel Pharmaceuticals Announces Reverse Stock Split - TipRanks

May 07, 2025
pulisher
May 07, 2025

Cyclacel Pharmaceuticals to implement 1-for-16 reverse stock split; shares fall - MSN

May 07, 2025
pulisher
May 07, 2025

Cyclacel Pharmaceuticals (CYCC) Plans 1-for-16 Reverse Stock Split | CYCC Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Cyclacel Pharmaceuticals Announces Stock Split - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Cyclacel Pharmaceuticals Announces 1-for-16 Reverse Stock Split Effective May 12, 2025 - Nasdaq

May 07, 2025
pulisher
May 07, 2025

CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT - The Manila Times

May 07, 2025
pulisher
May 06, 2025

Cyclacel Pharmaceuticals enters exchange agreement with Fitters - TipRanks

May 06, 2025
pulisher
May 06, 2025

Cyclacel Pharmaceuticals (CYCC) Plans Strategic Acquisition and Rebranding | CYCC Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCH - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Fitters swaps fire safety arm for 19.99% stake in Nasdaq biotech firm - The Malaysian Reserve

May 06, 2025
pulisher
May 06, 2025

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE - The Manila Times

May 06, 2025
pulisher
May 06, 2025

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

Cyclacel's Major Transformation: 80% Stake in Malaysian Fire Safety Leader Signals Strategic Pivot - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated by Analysts at StockNews.com - Defense World

May 02, 2025
pulisher
May 02, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

May 02, 2025
pulisher
Apr 30, 2025

Stocks of Cyclacel Pharmaceuticals Inc (CYCC) are poised to climb above their peers - Sete News

Apr 30, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 29, 2025

Examining Cyclacel Pharmaceuticals Inc (CYCC) more closely is necessary - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

The Psychology of Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 29, 2025
pulisher
Apr 25, 2025

Cyclacel Pharmaceuticals (CYCC) Announces Quarterly Dividend - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Cyclacel Pharmaceuticals expands share authorization By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

Cyclacel Pharmaceuticals expands share authorization - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Major Shareholders Set to Sell Stocks; Company (TICKER) to Reap No Proceeds | CYCC Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Cyclacel Pharmaceuticals Inc Inc. (CYCC) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Could Actually Go To 1 In 12 Months - Marketing Sentinel

Apr 25, 2025
pulisher
Apr 24, 2025

Was Cyclacel Pharmaceuticals Inc (CYCC)’s session last reading good? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Trading (CYCCP) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 21, 2025

Cyclacel Pharmaceuticals announces preferred stock dividend By Investing.com - Investing.com Canada

Apr 21, 2025

Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
자본화:     |  볼륨(24시간):